DaShenLin Pharmaceutical Group Co., Ltd.
603233
Rank in Stocks
#4876
Established in 1999, DaShenLin Pharmaceutical Group Co., Ltd. is a Chinese... Established in 1999, DaShenLin Pharmaceutical Group Co., Ltd. is a Chinese company based in Guangzhou. It operates across the pharmaceutical supply chain, engaging in the production, distribution, and direct sale of medicinal products throughout the country.
Share Price
$2.65
Market Cap
$3.02B
Change (1 day)
0.33%
Change (1 year)
1.22%
Country
CN
Trade DaShenLin Pharmaceutical Group Co., Ltd. (603233)
Category
Healthcare
Revenue for DaShenLin Pharmaceutical Group Co., Ltd. (603233)
Revenue in Jun 2026 TTM: $4.05B
According to DaShenLin Pharmaceutical Group Co., Ltd. latest financial reports the company's current revenue (TTM) is $4.05B. In 2023 the company made a revenue of $3.47B an increase over the revenue in the year 2022 that was $3.08B. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for DaShenLin Pharmaceutical Group Co., Ltd. from 2012 to 2026
Revenue at the end of each year
| Year | Revenue | Change |
|---|---|---|
| 2026 (TTM) | $4.05B | 11.66% |
| 2024 | $3.63B | 4.75% |
| 2023 | $3.47B | 12.51% |
| 2022 | $3.08B | 16.82% |
| 2021 | $2.64B | 18.12% |
| 2020 | $2.23B | 39.52% |
| 2019 | $1.60B | 24.23% |
| 2018 | $1.29B | 12.91% |
| 2017 | $1.14B | 26.23% |
| 2016 | $903.62M | 11.44% |
| 2015 | $810.85M | 10.50% |
| 2014 | $733.78M | 20.08% |
| 2013 | $611.08M | 17.16% |
| 2012 | $521.58M | 0.00% |
Revenue for similar companies or competitors
| Company | Revenue | Revenue Difference | Country |
|---|---|---|---|
| $12.62B | 211.45% |
US
|
|
| $2.23B | -45.03% |
US
|
|
| $15.74B | 288.43% |
AU
|
|
| - | - |
CH
|
|
| $6.02B | 48.55% |
NL
|
